(19)
(11) EP 4 815 936 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24898690.3

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
A61K 31/395(2006.01)
A61K 31/38(2006.01)
A61K 31/33(2006.01)
 A61K 31/16(2006.01)
A61K 31/496(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/496; A61K 9/1647; A61K 9/0019
(86) International application number:
PCT/US2024/057587
(87) International publication number:
WO 2025/117624 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603363 P

(71) Applicant: Oakwood Laboratories, Llc
Oakwood Village, OH 44146 (US)

(72) Inventors:
  • SPANOS, Alexander
    North Olmsted, Ohio 44070 (US)
  • CORNELL, Matthew
    Mayfield Heights, Ohio 44124 (US)
  • RICHEY, Tracy
    Stow, Ohio 44224 (US)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)

   


(54) MICROSPHERE FORMULATIONS COMPRISING BREXPIPRAZOLE AND METHODS FOR MAKING AND USING THE SAME